Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry: a Fundamental Shift in the Routine Practice of Clinical Microbiology
Clark, Andrew E. , Kaleta, Erin, Arora, Amit , Wolk, Donna M. , Clark, Andrew E.

Clinical Microbiology Reviews | July 3, 2013 | Volume: 26 | Issue: 3 | Pages: 547-603

10.1128/cmr.00072-12 | PMID 23824373 Get It

SUMMARY Within the past decade, clinical microbiology laboratories experienced revolutionary changes in the way in which microorganisms are identified, moving away from slow, traditional microbial identification algorithms toward rapid molecular methods and mass spectrometry (MS). Historically, MS was clinically utilized as a high-complexity method adapted for protein-centered analysis of samples in chemistry and hematology laboratories. Today, matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) MS is adapted for use in microbiology laboratories, where it serves as a paradigm-shifting, rapid, and robust method for accurate microbial identification. Multiple instrument platforms, marketed by well-established manufacturers, are beginning to displace automated phenotypic identification instruments and in some cases genetic sequence-based identification practices. This review summarizes the current position of MALDI-TOF MS in clinical research and in diagnostic clinical microbiology laboratories and serves as a primer to examine the “nuts and bolts” of MALDI-TOF MS, highlighting research associated with sample preparation, spectral analysis, and accuracy. Currently available MALDI-TOF MS hardware and software platforms that support the use of MALDI-TOF with direct and precultured specimens and integration of the technology into the laboratory workflow are also discussed. Finally, this review closes with a prospective view of the future of MALDI-TOF MS in the clinical microbiology laboratory to accelerate diagnosis and microbial identification to improve patient care.
Smoking and prostate cancer in a multi‐ethnic sample
Murphy, Adam B. , Akereyeni, Folasade, Nyame, Yaw A. , Guy, Mignonne C. , Martin, Iman K. , Hollowell, Courtney M.P. , Walker, Kelly, Ahaghotu, Chiledum, Kittles, Rick A.

The Prostate | July 3, 2013 | Volume: 73 | Issue: 14 | Pages: 1518-1528

10.1002/pros.22699 | PMID 23824512 Get It

ABSTRACTBACKGROUNDProstate cancer (PCa) and smoking‐related morbidity disproportionately burdens African American (AA) men. Smoking is associated with high‐grade PCa and incidence, but few studies have focused on AA men. This study aims to determine the effect of tobacco‐use on odds of PCa and of high‐grade PCa in a population of predominantly AA men.METHODSThis is a cross‐sectional study evaluating smoking and PCa status in men with incident PCa and screened healthy controls. Altogether, 1,085 men (527 cases and 558 controls), age ≥ 40 years were enrolled through outpatient urology clinics in two US cities from 2001 to 2012. Validated questionnaires were used to gather clinical and socioeconomic data.RESULTSThe cases and controls were predominantly AA (79.9% and 71.3%, respectively, P = 0.01). AA men smoked more frequently (53.4% vs. 47.9%, P < 0.001) and quit less frequently than European American (EA) men (31.5% vs. 40.4%, P = 0.01). AA heavy smokers had increased odds of PCa diagnosis (OR 2.57, 95% CI 1.09, 6.10) and high‐grade cancer (OR 1.89, 95% CI 1.03, 3.48) relative to never smokers and light smokers. Among AAs, heavy smokers had lower odds of being in the low risk stratification in the National Comprehensive Cancer Network guidelines. AA former smokers had a trend for increased odds of high‐grade cancer compared to never smokers. The associations between smokings, cancer diagnosis and cancer grade did not reach statistical significance in EA men.CONCLUSIONWe found ethnic differences in smoking behavior. Heavy smoking is associated with increased odds of PCa and of higher Gleason grade in AA men. Prostate 73: 1518–1528, 2013. © 2013 Wiley Periodicals, Inc.
Hyperinsulinemia and skeletal muscle fatty acid trafficking
Shadid, Samyah , Sheehan, Michael T. , Guo, ZengKui, Kanaley, Jill A, Kanaley, Jill A. , Jensen, Michael Dam

American Journal of Physiology-Endocrinology and Metabolism | July 3, 2013 | Volume: 305 | Issue: 4 | Pages: E540-E548

10.1152/ajpendo.00143.2013 | PMID 23820622 Get It

We hypothesized that insulin alters plasma free fatty acid (FFA) trafficking into intramyocellular (im) long-chain acylcarnitines (imLCAC) and triglycerides (imTG). Overnight-fasted adults ( n = 41) received intravenous infusions of [U-13C]palmitate (0400–0900 h) and [U-13C]oleate (0800–1400 h) to label imTG and imLCAC. A euglycemic-hyperinsulinemic (1.0 mU·kg fat-free mass−1·min−1) clamp (0800–1400 h) and two muscle biopsies (0900 h, 1400 h) were performed. The patterns of [U-13C]palmitate incorporation into imTG-palmitate and palmitoylcarnitine were similar to those we reported in overnight postabsorptive adults (saline control); the intramyocellular palmitoylcarnitine enrichment was not different from and correlated with imTG-palmitate enrichment for both the morning ( r = 0.38, P = 0.02) and afternoon ( r = 0.44, P = 0.006) biopsy samples. Plasma FFA concentrations, flux, and the incorporation of plasma oleate into imTG-oleate during hyperinsulinemia were ∼1/10th of that observed in the previous saline control studies ( P < 0.001). At the time of the second biopsy, the enrichment in oleoylcarnitine was <25% of that in imTG-oleate and was not correlated with imTG-oleate enrichment. The intramyocellular nonesterified fatty acid-palmitate-to-imTG-palmitate enrichment ratio was greater ( P < 0.05) in women than men, suggesting that sex differences in intramyocellular palmitate trafficking may occur under hyperinsulinemic conditions. We conclude that plasma FFA trafficking into imTG during hyperinsulinemia is markedly suppressed, and these newly incorporated FFA fatty acids do not readily enter the LCAC preoxidative pools. Hyperinsulinemia does not seem to inhibit the entry of fatty acids from imTG pools that were labeled under fasting conditions, possibly reflecting the presence of two distinct imTG pools that are differentially regulated by insulin.
Research Priority Setting
Vickrey, Barbara G. , Brott, Thomas G. , Koroshetz, Walter J.

Stroke | July 3, 2013 | Volume: 44 | Issue: 8 | Pages: 2338-2342

10.1161/strokeaha.113.001196 | PMID 23821224 Get It

Pili Annulati Masquerading As Hypotrichosis
Laniosz, Valerie, Podjasek, Joshua O., Camilleri, Michael , Hand, Jennifer L.

Pediatric Dermatology | July 3, 2013 | Volume: 30 | Issue: 4 | Pages: 510-511

10.1111/pde.12111 | PMID 23819454 Get It

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia
Ivan, Cristina , Shimizu, Masayoshi , Rabe, Kari G. , Nouraee, Nazila , Ikuo, Mariko, Ghosh, Asish K. , Rassenti, Laura Z., Xiao, Lianchun , Hu, Jianhua , Reuben, James M. , Calin, Steliana , You, M. James , Manning, John T. , Wierda, William G. , Keating, Michael J. , Călin, George A. , Calin, George A. , Ferrajoli, Alessandra , Shanafelt, Tait D. , Lerner, Susan A. , Wierda, William G. , Estrov, Zeev E. , O’Brien, Susan , Kipps, Thomas J. , Kay, Neil E. , Chaffee, Kari G.

Blood | July 3, 2013 | Volume: 122 | Issue: 11 | Pages: 1891-1899

10.1182/blood-2013-01-478222 | PMID 23821659 Get It

Key Points miR-155 levels are significantly and increasingly overexpressed as normal B cells progress to MBL and to CLL. Plasma levels of miR-155 before treatment were significantly lower in patients with CLL who experienced complete response than in all others.
Mammalian Dynamin-like Protein DLP1 Tubulates Membranes
Yoon, Yisang , Pitts, Kelly R., McNiven, Mark A.

Molecular Biology of the Cell | July 3, 2013 | Volume: 12 | Issue: 9 | Pages: 2894-2905

10.1091/mbc.12.9.2894 | PMID 11553726 Get It

Dynamins are large GTPases with mechanochemical properties that are known to constrict and tubulate membranes. A recently identified mammalian dynamin-like protein (DLP1) is essential for the proper cellular distribution of mitochondria and the endoplasmic reticulum in cultured cells. In this study, we investigated the ability of DLP1 to remodel membranes similar to conventional dynamin. We found that the expression of a GTPase-defective mutant, DLP1-K38A, in cultured cells led to the formation of large cytoplasmic aggregates. Electron microscopy (EM) of cells expressing DLP1-K38A revealed that these aggregates were comprised of membrane tubules of a consistent diameter. High-magnification EM revealed the presence of many regular striations along individual membrane tubules, and immunogold labeling confirmed the association of DLP1 with these structures. Biochemical experiments with the use of recombinant DLP1 and labeled GTP demonstrated that DLP1-K38A binds but does not hydrolyze or release GTP. Furthermore, the affinity of DLP1-K38A for membrane is increased compared with wild-type DLP1. To test whether DLP1 could tubulate membrane in vitro, recombinant DLP1 was combined with synthetic liposomes and nucleotides. We found that DLP1 protein alone assembled into sedimentable macromolecular structures in the presence of guanosine-5′-O-(3-thio)triphosphate (GTPγS) but not GTP. EM of the GTPγS-treated DLP1 revealed clusters of stacked helical ring structures. When liposomes were included with DLP1, formation of long membrane tubules similar in size to those formed in vivo was observed. Addition of GTPγS greatly enhanced membrane tubule formation, suggesting the GTP-bound form of DLP1 deforms liposomes into tubules as the DLP1-K38A does in vivo. These results provide the first evidence that the dynamin family member, DLP1, is able to tubulate membranes both in living cells and in vitro. Furthermore, these findings also indicate that despite the limited homology to conventional dynamins (35%) these proteins remodel membranes in a similar manner.
Transforming Growth Factor β Receptor Signaling and Endocytosis Are Linked through a COOH Terminal Activation Motif in the Type I Receptor
Garamszegi, Nandor, Doré, Jules J.E., Penheiter, Sumedha G., Edens, Maryanne, Yao, Diying, Leof, Edward B.

Molecular Biology of the Cell | July 3, 2013 | Volume: 12 | Issue: 9 | Pages: 2881-2893

10.1091/mbc.12.9.2881 | PMID 11553725 Get It

Transforming growth factor β (TGF-β) coordinates a number of biological events important in normal and pathophysiological growth. In this study, deletion and substitution mutations were used to identify receptor motifs modulating TGF-β receptor activity. Initial experiments indicated that a COOH-terminal sequence between amino acids 482–491 in the kinase domain of the type I receptor was required for ligand-induced receptor signaling and down-regulation. These 10 amino acids are highly conserved in mammalian, Xenopus, andDrosophila type I receptors. Although mutation or deletion of the region (referred to as the NANDOR BOX, for nonactivating non–down-regulating) abolishes TGF-β–dependent mitogenesis, transcriptional activity, type I receptor phosphorylation, and down-regulation in mesenchymal cultures, adjacent mutations also within the kinase domain are without effect. Moreover, a kinase-defective type I receptor can functionally complement a mutant BOX expressing type I receptor, documenting that when the BOX mutant is activated, it has kinase activity. These results indicate that the sequence between 482 and 491 in the type I receptor provides a critical function regulating activation of the TGF-β receptor complex.
Mechanisms of Transforming Growth Factor-β Receptor Endocytosis and Intracellular Sorting Differ between Fibroblasts and Epithelial Cells
Doré, Jules J.E., Yao, Diying, Edens, Maryanne, Garamszegi, Nandor, Sholl, Elizabeth L., Leof, Edward B.

Molecular Biology of the Cell | July 3, 2013 | Volume: 12 | Issue: 3 | Pages: 675-684

10.1091/mbc.12.3.675 | PMID 11251079 Get It

Transforming growth factor-βs (TGF-β) are multifunctional proteins capable of either stimulating or inhibiting mitosis, depending on the cell type. These diverse cellular responses are caused by stimulating a single receptor complex composed of type I and type II receptors. Using a chimeric receptor model where the granulocyte/monocyte colony-stimulating factor receptor ligand binding domains are fused to the transmembrane and cytoplasmic signaling domains of the TGF-β type I and II receptors, we wished to describe the role(s) of specific amino acid residues in regulating ligand-mediated endocytosis and signaling in fibroblasts and epithelial cells. Specific point mutations were introduced at Y182, T200, and Y249 of the type I receptor and K277 and P525 of the type II receptor. Mutation of either Y182 or Y249, residues within two putative consensus tyrosine-based internalization motifs, had no effect on endocytosis or signaling. This is in contrast to mutation of T200 to valine, which resulted in ablation of signaling in both cell types, while only abolishing receptor down-regulation in fibroblasts. Moreover, in the absence of ligand, both fibroblasts and epithelial cells constitutively internalize and recycle the TGF-β receptor complex back to the plasma membrane. The data indicate fundamental differences between mesenchymal and epithelial cells in endocytic sorting and suggest that ligand binding diverts heteromeric receptors from the default recycling pool to a pathway mediating receptor down-regulation and signaling.
Inositol 1,4,5-Trisphosphate Directs Ca2+Flow between Mitochondria and the Endoplasmic/Sarcoplasmic Reticulum: A Role in Regulating Cardiac Autonomic Ca2+Spiking
Jaconi, Marisa , Bony, Claire , Arnaudeau, Serge, Vassort, Guy, Pucéat, Michel , Richards, Stephen Michael , Terzic, André

Molecular Biology of the Cell | July 2, 2013 | Volume: 11 | Issue: 5 | Pages: 1845-1858

10.1091/mbc.11.5.1845 | PMID 10793156 Get It

The signaling role of the Ca2+releaser inositol 1,4,5-trisphosphate (IP3) has been associated with diverse cell functions. Yet, the physiological significance of IP3in tissues that feature a ryanodine-sensitive sarcoplasmic reticulum has remained elusive. IP3generated by photolysis of caged IP3or by purinergic activation of phospholipase Cγ slowed down or abolished autonomic Ca2+spiking in neonatal rat cardiomyocytes. Microinjection of heparin, blocking dominant-negative fusion protein, or anti-phospholipase Cγ antibody prevented the IP3-mediated purinergic effect. IP3triggered a ryanodine- and caffeine-insensitive Ca2+release restricted to the perinuclear region. In cells loaded with Rhod2 or expressing a mitochondria-targeted cameleon and TMRM to monitor mitochondrial Ca2+and potential, IP3induced transient Ca2+loading and depolarization of the organelles. These mitochondrial changes were associated with Ca2+depletion of the sarcoplasmic reticulum and preceded the arrest of cellular Ca2+spiking. Thus, IP3acting within a restricted cellular region regulates the dynamic of calcium flow between mitochondria and the endoplasmic/sarcoplasmic reticulum. We have thus uncovered a novel role for IP3in excitable cells, the regulation of cardiac autonomic activity.